WW International Reports Significant Q1 Revenue Decline, Negative Adjusted EBITDA, and Subscriber Loss Amid Ongoing Challenges
summarizeSummary
WW International reported a 9.6% year-over-year revenue decline, a negative Adjusted EBITDA, and a 22.6% drop in total subscribers for Q1 2026, highlighting continued operational headwinds and impairment risks.
check_boxKey Events
-
Q1 Revenue Decline
Net revenue decreased by 9.6% year-over-year to $168.3 million for Q1 2026.
-
Adjusted EBITDA Turns Negative
Adjusted EBITDA fell to $(1.8) million in Q1 2026, compared to $26.9 million in Q1 2025.
-
Significant Subscriber Loss
Total end-of-period subscribers declined by 22.6% year-over-year, primarily due to a drop in Behavioral subscribers.
-
Impairment Risk Identified
The Behavioral reporting unit and the trade name indefinite-lived intangible asset were identified as being at risk for impairment.
auto_awesomeAnalysis
The Q1 2026 results for WW International reveal a challenging period, marked by a substantial 9.6% decline in net revenue and a shift to a negative Adjusted EBITDA of $(1.8) million, down from $26.9 million in the prior year. The company also experienced a significant 22.6% decrease in total subscribers, primarily due to a sharp drop in its Behavioral business, which was impacted by bankruptcy-related media coverage and secular headwinds. While the Clinical business showed growth, it was insufficient to offset these declines. The disclosure of goodwill and trade name intangible assets being at risk for impairment further underscores the ongoing operational and market pressures, suggesting potential future write-downs. The recent CEO transition adds another layer of uncertainty. Although the company completed a voluntary debt prepayment, reducing principal by $14.6 million, the overall financial performance indicates a need for significant strategic improvements to stabilize the business.
At the time of this filing, WW was trading at $11.01 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $118M. The 52-week trading range was $8.91 to $80.14. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.